Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters
Friederike Hörster(Heidelberg University), Stefan Kölker(Heidelberg University), Halil İbrahim Aydın(Hacettepe University Hospital), Gülbin Gökçay(Istanbul University), Anibh M. Das(Medizinische Hochschule Hannover), S Geb(Goethe University Frankfurt), Esther M. Maier(Ludwig-Maximilians-Universität München), Matthias R. Baumgartner(University Children's Hospital Zurich), Frits A. Wijburg(Emma Kinderziekenhuis), T. Zwickler(Heidelberg University), Alberto Burlina(University of Padua), Nathalie Guffon(Hôpital Edouard Herriot), Éva Morava(Institut thématique Génétique, génomique et bioinformatique), Sven F. Garbade(Heidelberg University), Olaf A. Bodamer(Broad Institute), Carlo Dionisi‐Vici(Bambino Gesù Children's Hospital), Martin Lindner(Heidelberg University), J. B. C. de Klerk(Erasmus MC - Sophia Children’s Hospital), Bernd Schwahn(Boston Children's Hospital), J. H. Walter(Royal Manchester Children's Hospital), Stephanie Grünewald(Great Ormond Street Hospital)
Cited by 71
Related Papers
Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease
|Nature Microbiology|2019|1k
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
|Proceedings of the National Academy of Sciences|2008|725
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713
Suggested guidelines for the diagnosis and management of urea cycle disorders
|Orphanet Journal of Rare Diseases|2012|627